ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics

ProMIS Neurosciences has a market cap or net worth of $14.13M. The enterprise value is $24.61M.

ProMIS Neurosciences has 32,689,190 shares outstanding. The number of shares has decreased by -2.65% in one year.

ProMIS Neurosciences’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -100805.41%.

The current PE Ratio of ProMIS Neurosciences is <0.01. ProMIS Neurosciences’s PEG ratio is -1.42.

In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned 2.78B in profits. Earnings per share was 0.11.

In the last 12 months, operating cash flow was -21.25M and capital expenditures 0.00, giving a free cash flow of -21.73M billion.

ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

ProMIS Neurosciences upcoming earnings date is Aug 18, 2025, Before Open (Confirmed).

ProMIS Neurosciences as a current ratio of 8.52, with Debt / Equity ratio of 0.00%

In the past 12 months, ProMIS Neurosciences has paid 0.00 in taxes.

ProMIS Neurosciences EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.41.

ProMIS Neurosciences has $8.40M in cash and marketable securities with C$0.00 in debt, giving a net cash position of -$8.40M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ProMIS Neurosciences is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy